Umbilical Cord Blood Use For Admission Blood Tests of Very Low Birth Weight Preterm Neonates: A Multi-center Randomized Clinical Trial
Sponsor
Capt Alicia Prescott (U.S. Fed)
Overall Status
Completed
CT.gov ID
NCT02103296
Collaborator
C.R.Darnall Army Medical Center (U.S. Fed), Walter Reed National Military Medical Center (U.S. Fed), United States Naval Medical Center, Portsmouth (U.S. Fed), Madigan Army Medical Center (U.S. Fed), Tripler Army Medical Center (U.S. Fed)
80
6
2
89.7
13.3
0.1
Study Details
Study Description
Brief Summary
The goal of this protocol is to establish a randomized clinical trial comparing the use of cord blood vs. infant blood with the primary outcome of comparing both the absolute hemoglobin concentration and the percent change in hemoglobin concentration from baseline around 24 hours of life.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Study Type:
Interventional
Actual Enrollment
:
80 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Umbilical Cord Blood Use For Admission Blood Tests of Very Low Birth Weight (VLBW) Preterm Neonates: A Multi-center Randomized Clinical Trial
Study Start Date
:
Feb 1, 2014
Actual Primary Completion Date
:
Jul 25, 2021
Actual Study Completion Date
:
Jul 25, 2021
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Active Comparator: Infant Blood Control group. Admission labs to be drawn directly from the infant. |
Procedure: Drawing admission labs from infant blood
|
Experimental: Cord Blood Admission labs to be drawn from the infant's cord blood |
Procedure: Drawing admission labs from cord blood
|
Outcome Measures
Primary Outcome Measures
- Absolute hemoglobin concentration [24 hours of life]
- Percent change in hemoglobin concentration from baseline [24 hours of life]
Secondary Outcome Measures
- Number/volume of packed red blood cell (pRBC) transfusions [Participants will be followed from birth until time of hospital discharge, an expected average of 13 weeks]
- Number of blood donor exposures [Participants will be followed from birth until time of hospital discharge, an expected average of 13 weeks.]
- Use of Vasopressors [Participants will be followed from birth until time of hospital discharge, an expected average of 13 weeks.]
- Hemoglobin concentration at one week of life [one week]
- Hemoglobin concentration at time of hospital discharge [Approximately 10 - 16 weeks]
- Head Ultrasound [Read at 7 Days of life and at hospital discharge which is approximately 13 weeks of age]
Eligibility Criteria
Criteria
Ages Eligible for Study:
N/A
to 1 Day
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- Birth weight less than 1200g or Gestational Age less than 30 weeks born at participating medical centers
Exclusion Criteria:
- No specific exclusion criteria
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Tripler Army Medical Center | Honolulu | Hawaii | United States | 96859 |
2 | Walter Reed National Military Medical Center | Bethesda | Maryland | United States | 20889 |
3 | Carl R. Darnall Army medical Center | Fort Hood | Texas | United States | 78109 |
4 | San Antonio Military Medical Center | Fort Sam Houston | Texas | United States | 78234 |
5 | Portsmouth Naval Medical Center | Portsmouth | Virginia | United States | 23708 |
6 | Madigan Army Medical Center | Tacoma | Washington | United States | 98431 |
Sponsors and Collaborators
- Capt Alicia Prescott
- C.R.Darnall Army Medical Center
- Walter Reed National Military Medical Center
- United States Naval Medical Center, Portsmouth
- Madigan Army Medical Center
- Tripler Army Medical Center
Investigators
- Principal Investigator: Thornton S Mu, MD, San Antonio Military Medical Center
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Capt Alicia Prescott,
Associate Investogator,
San Antonio Military Medical Center
ClinicalTrials.gov Identifier:
NCT02103296
Other Study ID Numbers:
- 393720-1
First Posted:
Apr 3, 2014
Last Update Posted:
Aug 20, 2021
Last Verified:
Aug 1, 2021
Additional relevant MeSH terms: